Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, today reported 12-month results from an ongoing extension study with sebelipase alfa in adults with late onset Lysosomal Acid Lipase Deficiency.
[More]
A review of the available medical literature suggests that data on experience-related outcomes in children's surgery are limited and vary widely in methodologic quality, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.
[More]
Patients report “unexpectedly high” levels of pain after some relatively minor surgical procedures, including some laparoscopic procedures, say researchers.
[More]
Synageva BioPharma Corp. (Synageva), a clinical stage biopharmaceutical company developing therapeutic products for rare diseases, today announced publication of the 12-week Phase I/II extension study data of sebelipase alfa in adults with lysosomal acid lipase deficiency (LAL Deficiency) in the online version and an upcoming print edition of Hepatology
[More]
ARIAD Pharmaceuticals, Inc. today announced that following a priority review, the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Iclusig (ponatinib) for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that is resistant or intolerant to prior TKI therapy.
[More]
A study has found that young, less-experienced surgeons made major surgical mistakes almost half the time during a "simulated" gall bladder removal when they were distracted by noises, questions, conversation or other commotion in the operating room.
[More]
An acute care surgery model led to improvement in the quality of surgical patient care and reduced the cost of emergency surgical care at Loma Linda University Medical Center, report researchers who published their findings in the November issue of the Journal of the American College of Surgeons.
[More]
Bile duct injury significantly impairs survival after cholecystectomy, particularly when it goes undetected during surgery, show the results of a study published in the BMJ.
[More]
Researchers say that patients undergoing laparoscopic hysterectomy can be discharged the same day, with no associated safety concerns.
[More]
Medical rather than surgical management of acute cholecystitis – or inflamed gallbladder – may be the most appropriate option for elderly patients who may be unsuitable for surgery, report researchers.
[More]
The tradition of delaying laparoscopic cholecystectomy after hospital admission for mild gallstone pancreatitis may be unnecessary, say the authors of a US study.
[More]
In a simulated study, the rate of major errors committed while novice surgeons were exposed to typical interruptions and distractions was almost 50%, indicating that such exposure could seriously risk patient safety.
[More]
NHS hospitals have substantial scope to improve their efficiency by adopting best practice, according to research published today by Professor Andrew Street and colleagues at the Centre for Health Economics (CHE) at the University of York.
[More]
Studies from Stanford University, Cleveland Clinic Florida and the Naval Medical Center in San Diego show laparoscopic sleeve gastrectomy, an increasingly popular surgical procedure where the stomach is reduced by 85 percent, is as safe as or safer than laparoscopic gastric bypass or gastric banding. The studies* were presented here at the 29th Annual Meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS).
[More]
Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, today announced it has entered into a definitive agreement to acquire substantially all of the assets of Axiom Technology Partners, LLC, which makes the EFx family of laparoscopic fascial closure system products.
[More]
Surgeons at Valley Presbyterian Hospital (VPH) recently performed the hospital's first-ever single-port laparoscopic appendectomy, a minimally invasive surgical procedure for removing an infected appendix, which reduces scarring and healing time because it requires only one incision, Gustavo Valdespino, VPH president and CEO, announced today.
[More]
Taking advantage of another breakthrough in robotic surgery, a surgeon at Porter Adventist Hospital is among the first in the country and is the first in the Rocky Mountain Region to perform a robotically-assisted removal of the gallbladder through a single small incision.
[More]
Researchers at Wake Forest Baptist Medical Center in Winston-Salem, NC, have successfully created and implemented an emergency general surgery registry (EGSR) that will advance the science of acute surgical care by allowing surgeons to track and improve surgical patient outcomes, create performance metrics, conduct valid research and ensure quality care for all emergency general surgery (EGS) patients.
[More]
For more than 100 years, the traditional treatment for the painful growths called gallstones has been removal of the gallbladder, or cholecystectomy. But a new device, patented in China, promises to make removing the entire organ unnecessary. A group of scientists from the Second People's Hospital of Panyu District and Central South University in China have developed an endoscope specially designed for locating and clearing out gallstones and other gallbladder lesions.
[More]
On Tuesday, December 20th, Santiago Horgan, MD, chief of minimally invasive surgery at UC San Diego Health System was the first surgeon in the United States to remove a diseased gallbladder through a patient's belly button with the aid of a new FDA-approved da Vinci Si Surgical System.
[More]